MARKET

PRAX

PRAX

Praxis Precision Medicines, Inc.
NASDAQ
351.81
-3.34
-0.94%
After Hours: 351.81 0 0.00% 19:30 09/04 EDT
OPEN
352.99
PREV CLOSE
355.15
HIGH
357.50
LOW
349.82
VOLUME
175.36K
TURNOVER
--
52 WEEK HIGH
392.70
52 WEEK LOW
37.19
MARKET CAP
9.82B
P/E (TTM)
-27.2105
1D
5D
1M
3M
1Y
5Y
1D
S&P 500 Futures Drop In Premarket Trading; Praxis Precision Meds, Science Applications Lead
Dow Jones · 08/31 11:30
Weekly Report: what happened at PRAX last week (0824-0828)?
Weekly Report · 08/31 10:23
Weekly Report: what happened at PRAX last week (0817-0821)?
Weekly Report · 08/24 10:24
Praxis Precision Medicines Readies for Pivotal FDA Decisions
TipRanks · 08/23 00:05
Praxis Precision Med Is Maintained at Buy by Goldman Sachs
Dow Jones · 08/21 18:02
Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575
Benzinga · 08/21 17:52
Praxis Precision price target raised to $575 from $470 at Goldman Sachs
TipRanks · 08/21 10:25
Analysts Are Bullish on Top Healthcare Stocks: Unicycive Therapeutics (UNCY), Praxis Precision Medicines (PRAX)
TipRanks · 08/20 11:30
More
About PRAX
Praxis Precision Medicines, Inc. is an integrated, central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. The Company is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms. Its platform includes Cerebrum, a small-molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, an antisense oligonucleotide platform, is a targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The Company's product candidates include Ulixacaltamide, Vormatrigine, Relutrigine, PRAX-080, Elsunersen, and others.

Webull offers Praxis Precision Medicines Inc stock information, including NASDAQ: PRAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRAX stock methods without spending real money on the virtual paper trading platform.